Market Tracker

10/24 6:05pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

402.50
Data as of Oct 24
 +8.54 / +2.17%
Today’s Change
257.69
Today|||52-Week Range
404.60
+46.24%
Year-to-Date

Today’s Trading

Previous close393.96
Today’s open396.00
Day’s range393.21 - 404.60
Volume822,488
Average volume (3 months)812,399
Market cap$39.8B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)+25.00%
Earnings growth (next 5 years)+18.81%
Revenue growth (last year)+52.69%
P/E ratio112.1
Price/Sales12.80
Price/Book20.12

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.57+1.00%
ALNYAlnylam Pharmaceutic...+2.03+2.21%
CBSTCubist Pharmaceutica...-1.49-2.06%
ISISIsis Pharmaceuticals...+2.63+6.21%
Data as of 4:02pm ET, 10/24/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$2.56
Annual revenue (last year)$2.1B
Annual profit (last year)$424.4M
Net profit margin20.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts